Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
US9433618B2 · kind B2 · utility
2Cited by
14References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2016 |
| Grant date | Sep 6, 2016 |
| Priority date | — |
| Expiry date | Apr 13, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.